IEQ Capital’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Sell
73,545
-44,543
-38% -$1.62M 0.01% 670
2025
Q4
$3.83M Buy
118,088
+72,422
+159% +$2.26M 0.01% 599
2025
Q3
$1.29M Sell
45,666
-1,006
-2% -$28.9K ﹤0.01% 918
2025
Q2
$1.41M Buy
46,672
+17,134
+58% +$581K 0.01% 757
2025
Q1
$1.21M Sell
29,538
-73,747
-71% -$3.55M 0.01% 704
2024
Q4
$5.6M Buy
103,285
+99,723
+2,800% +$5.71M 0.05% 245
2024
Q3
$231K Buy
+3,562
New +$229K ﹤0.01% 1014

Other funds holding CRI

IEQ Capital's CRI Position: Q1 2026 in Review

IEQ Capital reduced its Carter's (CRI) stake by 38% in Q1 2026, selling an estimated $1.62M and leaving 73,545 shares worth $2.63M. The position accounts for 0.01% of the portfolio, ranked #670.

IEQ Capital first reported a position in CRI in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.6M in Q4 2024. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • IEQ Capital held 73,545 shares of Carter's worth $2.63M as of Q1 2026.
  • IEQ Capital sold 44,543 Carter's shares in Q1 2026, an estimated $1.62M.
  • Carter's made up 0.01% of IEQ Capital's portfolio in Q1 2026, its #670 holding.
  • IEQ Capital first reported a position in Carter's in Q3 2024 and has held it in 7 quarters since.
  • IEQ Capital's Carter's position peaked at $5.6M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.